PRAX Seeks Faster Development
Praxis Precision Medicines' seizure drug elsunersen receives Breakthrough Therapy Designation from the FDA after positive trial results
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Praxis Precision Medicines' seizure drug elsunersen receives Breakthrough Therapy Designation from the FDA after positive trial results